Module-Stage III NSCLC

Share

Program Content

Activities

  • ICIs in Stage III NSCLC: Recent Data
    Recent Data on Immune Checkpoint Inhibition After Chemoradiotherapy in Unresectable Stage III NSCLC
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 31, 2018

    Expires: October 30, 2019

Faculty

cover img faculity

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

Supporters

This CE activity is supported through an educational grant from

AstraZeneca